NFKB1 and neoplasm: Hence, the active NF-κB molecule in cancer is acting like a double-edged sword: on one hand, mediating the immune responses by eliminating tumour cells and, on the other hand, being constitutively active in renal cancer, arising from a chronic low-grade inflammatory milieu or rarely being activated by oncogenic aberrations [99].